This company seems to have been delisted
Reason: Acquired by Amgen
Last recorded trade on: November 25, 2022
Source: https://www.amgen.com/newsroom/press-releases/2022/08/amgen-to-acquire-chemocentryx-for-$4-billion-in-cash
Reason: Acquired by Amgen
Last recorded trade on: November 25, 2022
Source: https://www.amgen.com/newsroom/press-releases/2022/08/amgen-to-acquire-chemocentryx-for-$4-billion-in-cash
ChemoCentryx
CCXI
$86.33
Share price
0.00%
Change (1 day)
46.12%
Change (1 year)
Categories
Earnings for ChemoCentryx (CCXI)
Earnings in 2022 (TTM): -A$0.19 Billion
According to ChemoCentryx's latest financial reports the company's current earnings are A$37.2 Million. In 2021 the company made an earning of -A$0.22 Billion a decrease over its 2020 earnings that were of -A$87.53 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for ChemoCentryx from 2011 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2022 (TTM)  | -A$0.19 Billion | -15.56% |
| 2021 | -A$0.22 Billion | 144.84% |
| 2020 | -A$87.53 Million | -1.18% |
| 2019 | -A$88.58 Million | 45.17% |
| 2018 | -A$61.02 Million | -305.69% |
| 2017 | A$29.66 M | -144.7% |
| 2016 | -A$66.36 Million | -15.52% |
| 2015 | -A$78.55 Million | 0.85% |
| 2014 | -A$77.89 Million | 21.47% |
| 2013 | -A$64.12 Million | -1.24% |
| 2012 | -A$64.93 Million | 906.88% |
| 2011 | -A$6.45 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | A$3.16 B | -1,559.42% | 🇺🇸 USA |
 | A$6.17 B | -2,945.33% | 🇺🇸 USA |
 | A$7.29 B | -3,464.89% | 🇬🇧 UK |
 | -A$13.92 Billion | 6,315.77% | 🇺🇸 USA |
 | A$28.96 B | -13,455.28% | 🇺🇸 USA |
 | A$7.65 B | -3,629.10% | 🇺🇸 USA |
 | A$18.45 B | -8,609.19% | 🇺🇸 USA |
 | -A$0.47 Billion | 115.93% | 🇮🇱 Israel |
 | A$35.21 B | -16,338.13% | 🇺🇸 USA |